SCHEMBL19901062

SCHEMBL19901062

CC(=O)COc1cccc2ccc(C(C)C)nc12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.45
MCHR1 Q99705 5/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
NCF1 P14598 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19901540 0.88 PDE10A (0.49) PTGDR2MCHR1KDM4EMAPTLMNA
SCHEMBL8871879 0.81 PTGDR2 (0.64) NPC1RAB9APTGDR2KDM4EMAPT
SCHEMBL19901542 0.81 KMT2A (0.48) NPC1RAB9AMCHR1KDM4EMAPT
SCHEMBL8869916 0.79 NPC1 (0.52) NPC1RAB9APTGDR2MCHR1KDM4E
SCHEMBL8871046 0.78 MAPT (0.67) NPC1RAB9AKDM4EMAPTLMNA
SCHEMBL2850710 0.76 MCHR1 (0.59) NPC1RAB9AMCHR1KDM4EMAPT
SCHEMBL19901063 0.75 MCHR1 (0.41) NPC1RAB9AMCHR1LMNAALDH1A1
SCHEMBL10019487 0.70 NPC1 (0.49) NPC1RAB9APTGDR2KDM4EMAPT
SCHEMBL22672489 0.70 PARP1 (0.45) KDM4ELMNAALDH1A1HPGD
SCHEMBL8127612 0.69 ALDH1A1 (0.72) KDM4EMAPTLMNANPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902710-B2 Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) EXONHIT THERAPEUTICS, SA (FR) 2018-02-27 US disclosed